Drug Delivery Systems for Vascular Disease Therapy

[1]  P. Toth.  Pharmacomodulation of High-Density Lipoprotein Metabolism as a Therapeutic Intervention for Atherosclerotic Disease , 2010, Current cardiology reports.

[2]  G. Golomb,et al.  Liposomal Simvastatin Attenuates Neointimal Hyperplasia in Rats , 2010, The AAPS Journal.

[3]  David Siu.  A new way of targeting to treat coronary artery disease , 2010, Journal of cardiovascular medicine.

[4]  S. Caruthers,et al.  Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[5]  K. Robinson,et al.  Novel bioabsorbable salicylate‐based polymer as a drug‐eluting stent coating , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[6]  G. Golomb,et al.  Site-specific delivery of dexamethasone from biodegradable implants reduces formation of pericardial adhesions in rabbits. , 2006, Journal of biomedical materials research. Part A.

[7]  V. Muzykantov,et al.  Targeting of antioxidant and anti-thrombotic drugs to endothelial cell adhesion molecules. , 2005, Current pharmaceutical design.

[8]  Mair Zamir,et al.  Functional anatomy and hemodynamic characteristics of vasa vasorum in the walls of porcine coronary arteries. , 2003, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[9]  N. Rooijen,et al.  In vivo" depletion of macrophages by liposome-mediated "suicide". , 2003 .

[10]  P Serruys,et al.  Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group. , 1998, The New England journal of medicine.